Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 326

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Implications of COVID-19 for patients with pre-existing digestive diseases

Open access
Mao, Ren, Liang, Jie, Shen, Jun, Ghosh, Subrata, Zhu, Liang-Ru, Yang, Hong, Wu, Kai-Chun, Chen, Min-Hu · 2020 · The Lancet Gastroenterology & Hepatology

Abstract

www.thelancet.com/gastrohep Vol 5 May 2020 425 histological review; therefore, the absence of observed association of CRC in patients with ileocolonic disease location should be interpreted with caution. Patients without defined extent were categorised with patients with L3 (ileocecal extent), according to the Montreal Classification. Although the Montreal Classification is the standard classification for Crohn’s disease distribution in research studies, it does not differentiate the extent of colonic inflammation very well. Thus, I would not interpret this observation as patients with ileocolonic Crohn’s disease not being at risk for CRC. As long as current guideline recommendations have to rely on scant data, I would still include patients with ileocolonic Crohn’s disease and involvement of at least a third of the colon in CRC colonoscopy surveillance regimens. HRs of CRC-associated mortality numerically increased in more recent time periods, between 2003–17. Why was this occurring? It should be noted that the data sources were not consistent during all study periods, with only inpatient data available for earlier time periods (until 2001 in Sweden and 1995 in Denmark), which makes comparisons between time periods difficult. The most recent 2003–17 study period included the early biologic era as well as an early era for colonoscopy surveillance; the absence of reduction in incidence and mortality of Crohn’s disease-associated CRC despite improvements in management of Crohn’s disease is disappointing. This observation might imply a longer time period of followup is needed for improved mucosal inflammation to result in reduction in CRC risk; additional temporal CRC trends in Crohn’s disease will need to be studied. Likewise, the effect of colonoscopy surveillance in patients with Crohn’s disease, which only occurred towards the end of the study period, will have to be studied further. This study highlights the subgroup with the highest HR of CRC mortality are patients diagnosed with Crohn’s disease before the age of 40 years, compared with the age-stratified reference population. However, the highest absolute risk of CRC mortality remains among patients over 60 years of age. Despite society guidelines to advocate colonoscopy surveillance in patients with ulcerative colitis and Crohn’s disease, rates of colonoscopy surveillance even among high-risk patients with ulcerative colitis and primary sclerosing cholangitis remain abysmal. Health-care providers need to better communicate risk of CRC to patients with Crohn’s disease, and remove barriers to colonoscopy surveillance for patients at risk. Clinical researchers need to further refine their ability to stratify patients most likely to benefit from surveillance resources required for colonoscopy surveillance. To do so, they need more precise means of analysing the extent of Crohn’s disease, and they need to identify optimal colonoscopy surveillance intervals, which are currently still undefined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(20)30076-5

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 326

Metadata

Authors
Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L.-R., Yang, H., Wu, K.-C., & Chen, M.-H.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2020-05
Volume
5
Issue
5
Pages
425-427
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3009928515
Cited by
326
References
5
FWCI
9.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implications of COVID-19 for patients with pre-existing digestive diseases. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30076-5
The paper
Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L.-R., Yang, H., Wu, K.-C., & Chen, M.-H. (2020). Implications of COVID-19 for patients with pre-existing digestive diseases. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30076-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.